Research location
Augusta
Georgia, United States
Research activity in Augusta
Georgia, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 749 trials and 798 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Augusta
749 linked trials · page 1 of 15A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's MedicationsNCT07330258 · 2026-07-21 · 1 site observation
RECRUITING
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular EdemaNCT07592273 · 2026-06-01 · 1 site observation
RECRUITING
Longitudinal Natural History Study of Retinal Function in Eyes of Patients With DiabetesNCT07270133 · 2026-06-01 · 1 site observation
RECRUITING
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)NCT07361510 · 2026-03-12 · 1 site observation
RECRUITING
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor FluctuationsNCT07432958 · 2026-02-25 · 1 site observation
RECRUITING
A Study of Brenipatide in Adult Participants With SchizophreniaNCT07410507 · 2026-02-10 · 1 site observation
RECRUITING
A Trial to Test Intermittent Deep Brain Stimulation of Nucleus Basalis of Meynert to Treat Alzheimers.NCT07218081 · 2026-02-01 · 1 site observation
RECRUITING
Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)NCT07059962 · 2025-09-09 · 1 site observation
RECRUITING
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) InhibitorNCT07105111 · 2025-08-29 · 1 site observation
RECRUITING
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease PsychosisNCT06887192 · 2025-08-15 · 1 site observation
RECRUITING
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain MetastasesNCT06764940 · 2025-07-14 · 1 site observation
RECRUITING
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)NCT06898515 · 2025-07-14 · 1 site observation
RECRUITING
Lifestyle Intervention for Healthy ChangeNCT05956574 · 2025-04-01 · 1 site observation
RECRUITING
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial CancerNCT06989112 · 2025-03-27 · 1 site observation
RECRUITING
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood PressureNCT06742723 · 2025-03-03 · 1 site observation
RECRUITING
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's DiseaseNCT06680830 · 2025-01-17 · 1 site observation
RECRUITING
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart FailureNCT06526195 · 2024-12-13 · 1 site observation
RECRUITING
Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) TrialNCT06496256 · 2024-10-31 · 1 site observation
RECRUITING
A Study With NKT3964 for Adults With Advanced/Metastatic Solid TumorsNCT06586957 · 2024-09-19 · 1 site observation
RECRUITING
Mobile App Logging for Diabetes in PregnancyNCT06005987 · 2024-06-01 · 1 site observation
RECRUITING
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral HemorrhageNCT06402968 · 2024-06-01 · 1 site observation
RECRUITING
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsNCT06112418 · 2024-03-06 · 1 site observation
RECRUITING
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid TumorsNCT06293898 · 2024-02-09 · 1 site observation
RECRUITING
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25NCT05879926 · 2023-10-18 · 2 site observations
RECRUITING
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast CancerNCT05929768 · 2023-09-15 · 2 site observations
RECRUITING
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)NCT06126224 · 2023-08-28 · 1 site observation
RECRUITING
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart FailureNCT05677100 · 2023-08-23 · 1 site observation
RECRUITING
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung CancerNCT05624996 · 2023-07-12 · 1 site observation
RECRUITING
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot UlcersNCT05758545 · 2023-06-19 · 1 site observation
RECRUITING
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus PembrolizumabNCT05812807 · 2023-06-14 · 2 site observations
RECRUITING
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced CancerNCT05735080 · 2023-03-28 · 1 site observation
RECRUITING
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)NCT05579366 · 2022-12-07 · 1 site observation
RECRUITING
Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical TrialNCT05208190 · 2022-03-17 · 1 site observation
RECRUITING
Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEFNCT04592445 · 2020-12-18 · 1 site observation
RECRUITING
Type 1 Diabetes, Endothelin, and Skeletal Muscle Mitochondrial Dysfunction: The Role of Sirtuin-1NCT04449198 · 2020-10-14 · 1 site observation
RECRUITING
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor TypesNCT04300556 · 2020-08-06 · 1 site observation
RECRUITING
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung CancerNCT03851445 · 2019-02-06 · 1 site observation
RECRUITING
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate CancerNCT03678025 · 2018-09-24 · 1 site observation
RECRUITING
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMRNCT03142152 · 2018-01-01 · 1 site observation
RECRUITING
Observational Study of Pediatric Rheumatic Diseases: The CARRA RegistryNCT02418442 · 2015-07-01 · 1 site observation
RECRUITING
Exactech Shoulder Post Market Clinical Follow-up StudyNCT05603728 · 2007-07-19 · 1 site observation
RECRUITING
Continuous Delivery of Ranibizumab Via the Port Delivery System for Proliferative Diabetic Retinopathy-related Vitreous Hemorrhage With Pars Plana Vitrectomy and Limited PRP.NCT07864480 · 2026-09-01 · 1 site observation
NOT_YET_RECRUITING
Assessing Treatment With High-phenolic EVOO Supplements for Neurovascular ActivityNCT07741773 · 2026-09-01 · 1 site observation
NOT_YET_RECRUITING
Assessing Obesity Related Risk Factors in Adult Population: A Genetic and Behavioral StudyNCT07341841 · 2026-01-01 · 1 site observation
ENROLLING_BY_INVITATION
A Study to Assess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast CancerNCT06878248 · 2025-04-17 · 1 site observation
TERMINATED
Georgia Memory Net Anti-Amyloid Monoclonal Antibody RegistryNCT05999084 · 2025-03-06 · 1 site observation
ENROLLING_BY_INVITATION
A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01NCT06770933 · 2025-02-11 · 1 site observation
ACTIVE_NOT_RECRUITING
A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care ResourcesNCT06383988 · 2024-11-11 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)NCT06616974 · 2024-09-04 · 1 site observation
ACTIVE_NOT_RECRUITING
Glycemic Excursion Minimization (GEM) to Outshine Health DisparitiesNCT06236581 · 2024-06-20 · 1 site observation
UNKNOWN
How to interpret this record
CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.